NASDAQ:ISEE

IVERIC bio (ISEE) Price Target & Analyst Ratings

$37.67

-0.09 (-0.24%)

(As of 12:40 PM ET)

Compare

Today's Range: $37.65
▼
$37.85
50-Day Range: $22.64
▼
$38.05
52-Week Range: $8.85
▼
$38.25

Volume: 553,593 shs
Average Volume: 3.18 million shs
Market Capitalization: $5.19 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $27.45

IVERIC bio Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Hold
Based on 11 Analyst Ratings

Consensus Analyst Price Target

$27.45
-27.12% Downside

High Prediction	$35.00
Average Prediction	$27.45
Low Prediction	$18.00

Type	Current 5/30/22 to 5/30/23	1 Month Ago 4/30/22 to 4/30/23	3 Months Ago 3/1/22 to 3/1/23	1 Year Ago 5/30/21 to 5/30/22
Consensus Rating	Hold	Moderate Buy	Moderate Buy	Moderate Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	1 Buy rating(s)	8 Buy rating(s)	7 Buy rating(s)	6 Buy rating(s)
Hold	10 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)	1 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$27.45	$27.45	$27.30	$24.14
Predicted Upside	-27.12% Downside	61.25% Upside	73.68% Upside	72.93% Upside

Get IVERIC bio Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for ISEE and its competitors with MarketBeat's FREE daily newsletter.

ISEE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

ISEE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

IVERIC bio Stock vs. The Competition

Type	IVERIC bio	Medical Companies	S&P 500
Consensus Rating Score	2.09	2.66	2.48
Consensus Rating	Hold	Buy	Hold
Predicted Upside	-27.14% Downside	1,320.37% Upside	197.14% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Historical Target Prices and Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
5/5/2023	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold
5/4/2023	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral
5/3/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
5/2/2023	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Caufield Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
5/1/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Neutral
5/1/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Equal Weight
5/1/2023	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Nierengarten Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral
5/1/2023	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Neutral
2/21/2023	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Y. Zhi Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral	$17.00 ➝ $19.00	-13.44%
11/10/2022	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$30.00 ➝ $20.00	+2.51%
6/8/2022	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$18.00	+63.93%

(Data available from 5/30/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

ISEE Price Target - Frequently Asked Questions

What is IVERIC bio's consensus rating and price target?: According to the issued ratings of 11 analysts in the last year, the consensus rating for IVERIC bio stock is Hold based on the current 10 hold ratings and 1 buy rating for ISEE. The average twelve-month price prediction for IVERIC bio is $27.45 with a high price target of $35.00 and a low price target of $18.00. Learn more on ISEE's analyst rating history.
Do Wall Street analysts like IVERIC bio more than its competitors?: Analysts like IVERIC bio less than other Medical companies. The consensus rating for IVERIC bio is Hold while the average consensus rating for medical companies is Buy. Learn more on how ISEE compares to other companies.
Is IVERIC bio being downgraded by Wall Street analysts?: Over the previous 90 days, IVERIC bio's stock had 8 downgrades by analysts.

Does IVERIC bio's stock price have much upside?: According to analysts, IVERIC bio's stock has a predicted upside of 60.92% based on their 12-month price targets.
What analysts cover IVERIC bio?: IVERIC bio has been rated by Credit Suisse Group, Guggenheim, HC Wainwright, Morgan Stanley, Robert W. Baird, Stifel Nicolaus, UBS Group, and Wedbush in the past 90 days.

Stock Ratings Reports and Tools

This page (NASDAQ:ISEE) was last updated on 5/30/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial